A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma-Reference-Cited by-同舟云学术

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma

Published:2009-02 Issue:1 Volume:35 Page:9-17
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Shelley M.D.,Kumar S.,Wilt T.,Staffurth J.,Coles B.,Mason M.D.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference23 articles.

1. Studies on prostate cancer 1: the effect of castration of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer;Pisansky;Urol,2003

3. Radical perineal prostatectomy subsequent to bilateral orchidectomy;Vallet;Del Me J,1944

4. An evaluation of endocrine therapy plus radical prostatectomy in the treatment of advanced carcinoma of the prostate;Scott;J Urol,1964

5. Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy;Green;Int J Rad Oncol Biol Phys,1984

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genitourinary cancer neoadjuvant therapies: current and future approaches;Trends in Cancer;2023-12

2. Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer;The Prostate;2023-12

3. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer;Clinical Genitourinary Cancer;2023-12

4. Les grands principes des traitements du cancer de prostate localisé;Médecine Nucléaire;2023-11

5. Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol;European Urology Oncology;2023-10